Safety and Antibody Responses to Aerosolized MMR II Vaccine in Adults: An Exploratory Study

ISSN Print: 2160-5815
ISSN Online: 2160-5823
www.scirp.net/journal/wjv
E-mail: [email protected]

Citations

"Safety and Antibody Responses to Aerosolized MMR II Vaccine in Adults: An Exploratory Study"
written by Jose-Luis Diaz-Ortega, John V. Bennett, Deyanira Castaneda, Doris Ma Arellano, David Martinez, Jorge Fernandez de Castro,
published by World Journal of Vaccines, Vol.2 No.2, 2012

has been cited by the following article(s):

[1]	Prevalencia de anticuerpos frente a parotiditis en niños y adolescentes a dos años de haberse introducido la vacuna SRP
	2018

[2]	Antibody persistence in children aged 6–7years one year following booster immunization with two MMR vaccines applied by aerosol or by injection
	Vaccine, 2017

[3]	Antibody persistence in children aged 6–7 years one year following booster immunization with two MMR vaccines applied by aerosol or by injection
	Vaccine, 2017

[4]	Inhaled biologics: from preclinical to product approval
	Current Pharmaceutical Design, 2016

[5]	Relevant Facts from Aerosol Measles Vaccine Studies
	2016

[6]	The expanding role of aerosols in systemic drug delivery, gene therapy and vaccination: an update
	Translational Respiratory Medicine, 2014

[7]	Booster immune response in children 6–7 years of age, randomly assigned to four groups with two MMR vaccines applied by aerosol
	Vaccine. Elsevier, 2014

[8]	Safety and immunogenicity of dry powder measles vaccine administered by inhalation: A randomized controlled Phase I clinical tri
	Vaccine. Elsevier, 2014

[1]	Immunogenicity and safety of measles-mumps-rubella vaccine delivered by the aerosol, intradermal and intramuscular routes in previously vaccinated young adults: a randomized controlled trial protocol PLOS ONE, 2025 DOI:10.1371/journal.pone.0318893

[2]	Antibody persistence in children aged 6–7 years one year following booster immunization with two MMR vaccines applied by aerosol or by injection Vaccine, 2017 DOI:10.1016/j.vaccine.2017.04.027

[3]	Prevalencia de anticuerpos frente a parotiditis en niños y adolescentes a dos años de haberse introducido la vacuna SRP Salud Pública de México, 2017 DOI:10.21149/8138

[4]	Relevant Facts from Aerosol Measles Vaccine Studies World Journal of Vaccines, 2016 DOI:10.4236/wjv.2016.63006

[5]	The expanding role of aerosols in systemic drug delivery, gene therapy and vaccination: an update Translational Respiratory Medicine, 2014 DOI:10.1186/2213-0802-2-3

[6]	Booster immune response in children 6–7 years of age, randomly assigned to four groups with two MMR vaccines applied by aerosol or by injection Vaccine, 2014 DOI:10.1016/j.vaccine.2014.04.031

[7]	Safety and immunogenicity of dry powder measles vaccine administered by inhalation: A randomized controlled Phase I clinical trial Vaccine, 2014 DOI:10.1016/j.vaccine.2014.09.071